LIPOLAT Trademark

Trademark Overview

On Monday, April 6, 2015, a trademark application was filed for LIPOLAT with the United States Patent and Trademark Office. The USPTO has given the LIPOLAT trademark a serial number of 86588503. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, October 11, 2025. This trademark is owned by Peregrine Ophthalmic PTE LTD.. The LIPOLAT trademark is filed in the Pharmaceutical Products category with the following description:

Liposomal drug delivery agent consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in the treatment of disease
lipolat

General Information

Serial Number86588503
Word MarkLIPOLAT
Filing DateMonday, April 6, 2015
Status800 - REGISTERED AND RENEWED
Status DateSaturday, October 11, 2025
Registration Number4979418
Registration DateTuesday, June 14, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 1, 2015

Trademark Statements

Goods and ServicesLiposomal drug delivery agent consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in the treatment of disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 14, 2015
Primary Code005
First Use Anywhere DateWednesday, June 17, 2015
First Use In Commerce DateWednesday, June 17, 2015

Trademark Owner History

Party NamePeregrine Ophthalmic PTE LTD.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSingapore 558445
SG
Party NamePeregrine Ophthalmic PTE LTD.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSingapore 558445
SG
Party NamePeregrine Ophthalmic PTE LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSingapore 558445
SG

Trademark Events

Event DateEvent Description
Thursday, April 9, 2015NEW APPLICATION ENTERED
Tuesday, April 14, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 14, 2015ASSIGNED TO EXAMINER
Tuesday, July 14, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 14, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, July 14, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 14, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, July 14, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 27, 2015ASSIGNED TO LIE
Monday, July 27, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 12, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 1, 2015PUBLISHED FOR OPPOSITION
Tuesday, September 1, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 27, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 11, 2016TEAS STATEMENT OF USE RECEIVED
Thursday, April 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 11, 2016USE AMENDMENT FILED
Monday, April 18, 2016STATEMENT OF USE PROCESSING COMPLETE
Sunday, May 8, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 10, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 14, 2016REGISTERED-PRINCIPAL REGISTER
Monday, June 14, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 30, 2021TEAS SECTION 8 & 15 RECEIVED
Sunday, October 10, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, October 10, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, October 10, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, June 14, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, June 19, 2025TEAS SECTION 8 & 9 RECEIVED
Thursday, July 17, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 17, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 17, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 17, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 17, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 17, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 11, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 11, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, October 11, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, October 11, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, December 18, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 18, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 18, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, December 18, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

lipolat delivery range pharmaceuticals treatment wide disease compounds drug agent consisting